Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients

Annals of Neurology

Volumn 43, Issue 3, 1998, Pages 340-349

  Martino, Gianvito ^a   Grohovaz, Fabio ^a   Brambilla, Elena ^a   Codazzi, Franca ^a   Consiglio, Antonella ^a   Clementi, Emilio ^b   Filippi, Massimo ^a   Comi, Giancarlo ^a   Grimaldi, Luigi M E ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN RECOGNITION; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; DEMYELINATION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS; BLOOD CELLS; CALCIUM; CELL DIVISION; CROSS-SECTIONAL STUDIES; CYTOKINES; DRUG SYNERGISM; HUMANS; INFLAMMATION MEDIATORS; INTRACELLULAR MEMBRANES; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; MYELIN SHEATH; OSMOLAR CONCENTRATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031889913     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430312     Document Type: Article

References (34)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10: 153-187
2. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of non specific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 1996; 93:2253-2256
3. Goverman J, Woods A, Larson L, et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-560
4. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994;78:399-408
5. Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994;180:1159-1164
6. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996;272:1947-1950
7. Panitch NL, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987;1:893-895
8. Panitch NL, Hirsch RL, Schindler J, Johnson KP. Treatment of MS with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987;37:1097-1102
9. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995;44:245-268
10. Beck J, Rondot P, Catinot L, et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988;78:318-323
11. Maimone D, Reder AT, Gregory S. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. Cell Immunol 1993;146:96-106
12. Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472
13. 2+ influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA 1994;91:4825-4829
14. 2+ influx in patients with relapsing-remitting multiple sclerosis. Neurology 1996;46:1416-1421
15. Negulescu PA, Shastri N, Cahalan MD. Intracellular calcium dependence of gene expression in single T lymphocyte. Proc Natl Acad Sci USA 1994;91:2873-2877
16. Martino G, Moiola L, Brambilla E, et al. γ-Interferon induces T-lymphocyte proliferation in multiple sclerosis via a calcium-dependent mechanism. J Neuroimmunol 1995;62:169-176
17. Rudick R, Antel J, Confavreux C, et al. Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996;40:469-479
18. 2+ influx: two independently regulated mechanisms of influx stimulation coexist in neurosecretory PC12 cells. J Biol Chem 1992;267:2164-2172
19. 2+ signaling. J Cell Biol 1995;129:797-804
20. Seuwen K, Lagarde A, Pouyssegur J. Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide-specific phospholipase C. EMBO J 1988;7:161-168
21. 2+ release neurosecretory PC-12 cells: inhibition of phospholipase C activity cyclic GMP-dependent protein kinase I. Mol Pharmacol 1995;47: 517-524
22. Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Annu Rev Immunol 1995;13:623-653
23. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34: 661-669
24. Vink A, Uyttenhove C, Wauters P, Van Snick J. Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor. Eur J Immunol 1990;20:1-6
25. Schumann MA, Gardner P, Raffin TA. Recombinant human tumor necrosis factor alpha induces calcium oscillation and calcium-activated chloride current in human neutrophils. The role of calcium/calmodulin-dependent protein kinase. J Biol Chem 1993;268:2134-2140
26. Holliday J, Parsons K, Curry J, et al. Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture. Brain Res 1995;673:141-148
27. Navikas V, Matusevicius D, Sodestrom M, et al. Interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996;64: 63-69
28. Sibley WA, Bamford CR, Clark K. Clinical viral infections and MS. Lancet 1985;1:1313-1315
29. Martino G, Filippi M, Martinelli V, et al. Interferon-γ induced increases in intracellular calcium in T lymphocytes from patients with multiple sclerosis precede clinical exacerbations and detection of active lesions on MRI. J Neurol Neurosurg Psychiatry 1997;63:339-345
30. Khan OA, Xia Q, Bever CT Jr, et al. Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 1996;46:1639-1643
31. Trinchieri G, Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985;6:131-136
32. Weinstock-Guttman B, Ransohoff RM, Kinkel RP, Rudick RA. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 1995;37:7-15
33. Sanceau J, Kaisho T, Hirano T, Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J Biol Chem 1995;270:27920-27931
34. Cambi F, Lees MB, Williams RM, Macklin WB. Chronic experimental allergic encephalomyelitis produced by bovine proteolipid apoprotein: immunologicai studies in rabbits. Ann Neurol 1983;13:303-308